FA
Fate Ther
FATE·NASDAQSan Diego CAFounded 2007450 employees
Small CapbiotechPublicOncology
Platform: iPSC NK
Market Cap
$0.5B
All Drugs
2
Clinical Trials
8
Failed / Terminated
0
FDA Approved
1
Stock Price & Catalysts (FATE)
Loading FATE stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Talainavolisib | FAT-5475 | Approved | 4 | KIF18A | ACCADPKD | ||
| Kemanaritide | FAT-1071 | Phase 3 | 4 | JAK2 | ACC |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (7)